<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Duggirala A</submitter><funding>British Heart Foundation</funding><funding>NIHR Bristol BRU in Cardiovascular Medicine</funding><pagination>157-68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4312355</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>79</volume><pubmed_abstract>Elevation of intracellular cAMP concentration has numerous vascular protective effects that are in part mediated via actin cytoskeleton-remodelling and subsequent regulation of gene expression. However, the mechanisms are incompletely understood. Here we investigated whether cAMP-induced actin-cytoskeleton remodelling modulates VSMC behaviour by inhibiting expression of CCN1. In cultured rat VSMC, CCN1-silencing significantly inhibited BrdU incorporation and migration in a wound healing assay. Recombinant CCN1 enhanced chemotaxis in a Boyden chamber. Adding db-cAMP, or elevating cAMP using forskolin, significantly inhibited CCN1 mRNA and protein expression in vitro; transcriptional regulation was demonstrated by measuring pre-spliced CCN1 mRNA and CCN1-promoter activity. Forskolin also inh</pubmed_abstract><journal>Journal of molecular and cellular cardiology</journal><pubmed_title>cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.</pubmed_title><pmcid>PMC4312355</pmcid><funding_grant_id>PG/11/78/29113</funding_grant_id><pubmed_authors>Sala-Newby GB</pubmed_authors><pubmed_authors>Johnson JL</pubmed_authors><pubmed_authors>Kimura TE</pubmed_authors><pubmed_authors>Newby AC</pubmed_authors><pubmed_authors>Wu YJ</pubmed_authors><pubmed_authors>Duggirala A</pubmed_authors><pubmed_authors>Bond M</pubmed_authors></additional><is_claimable>false</is_claimable><name>cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1.</name><description>Elevation of intracellular cAMP concentration has numerous vascular protective effects that are in part mediated via actin cytoskeleton-remodelling and subsequent regulation of gene expression. However, the mechanisms are incompletely understood. Here we investigated whether cAMP-induced actin-cytoskeleton remodelling modulates VSMC behaviour by inhibiting expression of CCN1. In cultured rat VSMC, CCN1-silencing significantly inhibited BrdU incorporation and migration in a wound healing assay. Recombinant CCN1 enhanced chemotaxis in a Boyden chamber. Adding db-cAMP, or elevating cAMP using forskolin, significantly inhibited CCN1 mRNA and protein expression in vitro; transcriptional regulation was demonstrated by measuring pre-spliced CCN1 mRNA and CCN1-promoter activity. Forskolin also inh</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Feb</publication><modification>2025-04-19T14:40:46.548Z</modification><creation>2019-03-27T01:44:21Z</creation></dates><accession>S-EPMC4312355</accession><cross_references><pubmed>25446180</pubmed><doi>10.1016/j.yjmcc.2014.11.012</doi></cross_references></HashMap>